Regenesis Biomedical appoints Tom Eisiminger to its Board of Directors as CEO

– USA, AZ –  Regenesis Biomedical, Inc., a medical device company focused on safe, non-drug, pain management, today announced the election of Tom Eisiminger, Jr., to its Board of Directors as President and CEO, succeeding Scott Brooks who recently retired.

About Tom Eisiminger

Tom Eisiminger has been with Regenesis Biomedical for 14 years leading the sales efforts. Tom served in successive leadership roles culminating in his most recent position as VP of Sales. Tom served our country in the Army for 20+ years and is a decorated combat veteran. He held numerous leadership positions from platoon to battalion command and twice earned awards as the top recruiting unit in the Army. Tom is a member of the Veterans of Foreign Wars, the American Legion, and the Disabled American Veterans. He is a veteran’s advocate and serves as President of the Veterans Medical Leadership Council and is a member of the Arizona Veterans Hall of Fame Class of 2018.

He currently serves on the Board of Directors of the American Diabetes Association – Arizona, New Mexico, and Utah chapter.

“I look forward to leading Regenesis towards accelerated growth with our team of dedicated colleagues,” said CEO Tom Eisiminger. “To accomplish growth and market expansion, we will focus on these key value drivers: Clinical evidence, new FDA-cleared indications, intellectual property, and product development. I am pleased that the current senior management team will continue in the new leadership structure.”

He earned his B.S. from the U.S. Military Academy at West Point, his M.A. in National Security and Strategic Studies from the Naval War College, and his MBA from Marylhurst University.

About Regenesis Biomedical

Regenesis Biomedical, Inc., is a privately held medical device company dedicated to improving human welfare through the research, design, manufacture, and sale of energy-based medical products and services that alleviate pain, restore health, and improve quality of life. Regenesis developed, patented, and markets the Provant Therapy System. We are focused today on serving the needs of Veterans through our direct salesforce. Over 20,000 patients have been treated with Provant’s safe, non-drug, electromagnetic energy for pain management.

For more information: https://www.regenesisbio.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.